Monthly Archives: June 2020

Erythropoietin (EPO) Drugs Market Business Opportunity And Future Growth Analysis Report 2026 | Reports and Data

The Erythropoietin (EPO) Drugs Market Report by Reports and Data provides an extensive overview of the vital elements of the Erythropoietin (EPO) Drugs market and factors such as drivers, restraints, latest trends, supervisory scenario, competitive landscape, technological advancements, and others.

New York City, United States – June 29, 2020 /MarketersMedia/

The report proposes a full-fledged solution for all your business needs and helps in understanding the overall dynamics of the market. The market report offers an in-depth evaluation of all aspects that are expected to impact the growth of the market in a constructive way. The report focuses on the idea of aiming at the targeted customer’s needs and wants. The report also tells how effectively a company can meet its requirements. This Erythropoietin (EPO) Drugs market research collects and analyses reliable data about the customers, their marketing strategies, competitors, and others.

This is the latest report covering the current COVID-19 scenario. The coronavirus pandemic has greatly affected every aspect of the worldwide industry. It has brought along various changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact are covered in the research report. The report discusses all the major aspects of the market with expert opinions on the current status along with historical data.

Get a sample PDF copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/1607

Key players mentioned in the research report are:
Johnson & Johnson, Celltrion, Inc., Teva Pharmaceutical Industries Ltd., Amgen Inc., Hoffman-La Roche Ltd., LG Life Sciences Ltd., Biocon Limited, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd.

In terms of applications, the global Erythropoietin (EPO) Drugs market can be segmented into:
Cancer
Hematology
Renal diseases
Neurology

In terms of types, the global Erythropoietin (EPO) Drugs market can be segmented into:
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
And others

The Erythropoietin (EPO) Drugs Market is analyzed on the basis of dynamics of demand and supply, pricing, total volume produced, revenue generated, and others. The manufacturing is studied on the basis of several factors such as manufacturing plant distribution, industry production, production capacity, and research and development. It also delivers accurate market evaluations with the use of SWOT analysis, investment analysis, returns analysis, and growth trend analysis, and others.

To get a discount on the report, click @ https://www.reportsanddata.com/discount-enquiry-form/1607

For geographical segmentation, regional supply, application-wise, and type-wise demand, key players, and others, this report covers the following regions: North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The report sheds light on the competitive landscape of the market that covers the product offerings, services, market shares, and business overview. This Erythropoietin (EPO) Drugs Market research report covers various dynamic aspects like the market drivers, restraints and challenges, and growth prospects. The prominent and leading companies are profiled in the report.

Key coverage of the report:
• Detailed overview of Erythropoietin (EPO) Drugs Market
• In-depth analysis of the changing Erythropoietin (EPO) Drugs Market dynamics
• Market segmentation by type, application, region, etc.
• Historical, current, and projected Erythropoietin (EPO) Drugs Market size in terms of both volume and value
• Latest industry trends and technological developments
• Competitive landscape of the global Erythropoietin (EPO) Drugs Market
• Key strategies of major players
• Potential segments/regions exhibiting promising growth opportunities

Reasons to buy the report:
• Extensive analysis of the market on both global and regional levels.
• Major changes in the competitive landscape.
• Segmentation on the basis of type, application, geography, and others.
• Historical and future market forecast in terms of size, share, growth, volume & sales.
• Key changes in the market’s overall dynamics & developments.
• Industry size & share analysis along with growth trends.
• New emerging segments and regions.
• Prevalent business strategies by key market players.

Get the full report description, TOC, Table of Figures, Charts @ https://www.reportsanddata.com/report-detail/erythropoietin-epo-drugs-market

This research report delivers a 360 overview of the competitive landscape of the Global Erythropoietin (EPO) Drugs Market. Furthermore, it includes massive data regarding the latest trends, technological advancements, and methodologies. The study analyzes the Global Erythropoietin (EPO) Drugs Market in a detailed and extensive manner for the readers to gain better insights.

Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.

About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development. You can rely on us to provide every significant detail you might need in your efforts to make your business flourish.

Contact Info:
Name: John Watson
Email: Send Email
Organization: Reports And Data
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Phone: +1-212-710-1370
Website: https://www.reportsanddata.com/

Source URL: https://marketersmedia.com/erythropoietin-epo-drugs-market-business-opportunity-and-future-growth-analysis-report-2026-reports-and-data/88966337

Source: MarketersMedia

Release ID: 88966337

Superabsorbent Polymers Market Riding the High Wave on the back of Surging Demand from Disposable Diaper Industry – Future Market Insights

A large geriatric population pool has led to an uptick in the demand for disposable diapers in recent years. As the percentage of old people increase, chronic ailments such as fecal incontinence and urinary malfunctions have also augmented. This has stimulated demand for diapers which extensively utilize super absorbent polymers.

DUBAI, UAE / ACCESSWIRE / June 29, 2020 / Over the years, super absorbent polymers have been gaining immense traction for a variety of end-uses. Invented in the 1970s in Japan, super absorbent polymers are derived from an amalgamation of sodium hydroxide and acrylic acid. Super absorbent polymers are primarily used in producing feminine and disposable hygiene products, disposable diapers, sand bags, artificial snow and absorbent pads. These polymers are used to manufacture aqueous solutions for diapers, absorbent pads and adult incontinence products.

Superabsorbent polymers have taken the diaper industry by storm. Manufacturers effectively exploited their liquid retention capacity. These polymers absorb and retain nearly 30 times their weight in urine. The swollen gel within the diaper preserves the liquid in a rubbery state, preventing any leakage. Based on this trend, the superabsorbent polymers market is anticipated to reach a volume of ~3000 tons by the end of 2020.

"Mushrooming population across the Asia-Pacific region is prompting diaper manufacturers to initiate their businesses in this region. Massive demand and production across emerging economies such as South Korea, Japan, China and India is compounding usage of superabsorbent polymers," concludes a prominent analyst at FMI.

Request report sample in order to acquire in-depth market insights on https://www.futuremarketinsights.com/reports/sample/rep-gb-429

Superabsorbent Polymers Market- Key Takeaways

Adult incontinent products constituted 12% of the superabsorbent polymers market during the historical period. This trend is expected to continue in the future.
Feminine hygiene products are gaining significant momentum, attributed to growing awareness about women's health.
The superabsorbent polymers market shall be valued at US$ 7.7 Bn by 2020, expanding at a moderate CAGR of 4% since 2015.
Asia-Pacific shall pivot the global superabsorbent polymers market in the future.

Superabsorbent Polymers Market- Prominent Drivers

Rising demand for fluffless diapers is catapulting superabsorbent polymers usage in the diapers industry. Their ability to disperse the moisture instead of collecting it is boosting their popularity.
Need for effective management of water resources during irrigation is pushing adoption of superabsorbent polymers. It is reported that over 30% of the water can be conserved using superabsorbent polymers.

Superabsorbent Polymers Market- Key Constraints

Volatility in prices of raw materials used to manufacture superabsorbent polymers is proving to be a hindrance to market growth.
Concerns regarding effective disposal of non-biodegradable superabsorbent polymer based diapers is discouraging consumers from purchasing them.

Anticipated Impact of the Coronavirus Pandemic

The superabsorbent polymers market has experienced a significant production crunch in the wake of the coronavirus pandemic. As countries have imposed nationwide lockdowns, manufacturing units are either completely shut or operating at half their capacities. Moreover, social distancing measures have disrupted logistical arrangements, leading to problems in procuring raw materials for production. In addition, these raw materials have skyrocketed in terms of cost as there is a severe shortage. Fortunately, market players are leveraging their supply chains by consolidating their online sales platforms in order to deliver their products to their consumers. Customers are increasingly purchasing diapers through online retail outlets, keeping the market afloat. Moreover, certain countries have now started to relax lockdowns, permitting transportation and production to revert to normalcy. This is anticipated to retain much of the lost revenue during the first two quarters of 2020.

Explore the superabsorbent polymers report with illustrative figures, data tables and the table of contents. You can also find a detailed market segmentation on https://www.futuremarketinsights.com/askus/rep-gb-429.

Competition Landscape

Prominent market players in the superabsorbent polymers market include Kao Corporation, Sumitomo Seika Chemicals Ltd., Yixing Danson Technology, San-Dia Polymers Global Co. Ltd, Evonik, Nippon Shokubai, Formosa Plastics, Sanyo Chemicals and BASF. Portfolio expansion, new product launches, partnership and collaboration agreements constitute the principal strategies adopted by these player to consolidate their footing in the market and expand their customer base. In April 2017, Evonik launched its FAVOR max superabsorbent diapers for infants which greatly helped augment their sales in the market. Likewise, in 2018, Nippon expanded its superabsorbent polymer manufacturing facility in the Netherlands to cater to the ever-increasing demand.

More Insights on the Super Absorbent Polymers Market

FMI's seminal research report on the super absorbent polymers market provides an unbiased analysis of the key dynamics impacting growth prospects for the period 2015-2020. Market analysis has been conducted by virtue of the following three segments: product type, application and geography. Based on product type, the market has been divided into sodium polyacrylate and polyacrylamide co-polymer. By application, the market is segmented into adult incontinence products, feminine hygiene products, disposable diapers and others. Based on geography, the market is divided into North America, Europe, Japan, Asia-Pacific Excluding Japan (APEJ), Latin America and Middle East & Africa (MEA).

Explore FMI's Extensive Coverage on the Chemicals & Materials Landscape

Magnesium Carbonate Minerals Market: Explore FMI's recently published research report on the magnesium carbonate minerals market for the forecast period 2020-2030 to obtain information regarding key dynamics responsible for shaping the market landscape during the aforementioned time period.

Precast Concrete Market: Investigate how booming digital economies in the Asia-Pacific are exhaustively utilizing precast concrete in FMI's recently concluded research report on the market for the forecast period 2020-2030.

Direct Reduced Iron (DRI) Market: FMI's recent report on the DRI market delivers a comprehensive assessment of the most important growth dynamics based on current growth parameters for the period 2020-2030.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Market Report: https://www.futuremarketinsights.com/reports/super-absorbent-polymer-market
Press Release Source: https://www.futuremarketinsights.com/press-release/super-absorbent-polymer-market-key-companies

SOURCE: Future Market Insights

ReleaseID: 595079

UNest’s CEO Ksenia Yudina named to InvestmentNews’ 40 Under 40 List

NORTH HOLLYWOOD, CA / ACCESSWIRE / June 29, 2020 / InvestmentNews has recognized Ksenia Yudina, CEO and founder of the college and family savings fintech company UNest, as a 2020 40 Under 40 Honoree. Ksenia was chosen as one of 40 talented individuals from a pool of approximately 1,000 nominees by a panel of reporters, editors and other representatives of InvestmentNews.

"I'm honored to be named to this prestigious group of financial advisors and investment professionals," said Ksenia Yudina, CEO and founder of UNest. "As a company founder, it's important to surround yourself with experienced entrepreneurs and advisors who believe in your vision. I've been fortunate to have a great team who share my vision for UNest, and my outlook on building a company, which is to be persistent and never give up."

After earning her MBA and CFA charter, Ksenia became a Vice President at Capital Group/American Funds, the largest 529 provider in the United States. She learned first hand the problems families face when saving for their childrens' education. Ksenia saw the tedious paperwork that stymied financial advisors, and the expensive costs associated with 529 plans, making them typically available only to affluent families. These experiences, coupled with motherhood (Ksenia has three kids), served as her inspiration for founding UNest, which helps parents invest in their childrens' future, and serves as a fundamental pillar in their financial planning. Families of all income levels and backgrounds can save easily through UNest's app. UNest operates as a fully-certified RIA.

"The 2020 class of 40 Under 40 honorees represent the best of the future of the financial advice community," said George B. Moriarty, Chief Content Officer of InvestmentNews. "These men and women have already made their marks on the industry through exceptional leadership and service to their communities."

The recognition as a 40 Under 40 Honoree comes on the heels of UNest's recently announced $9 million Series A round this month. The company attracted investments from return investors Anthos Capital and Northwestern Mutual Future Ventures, as well as NBA All-Star Baron Davis, who also joined as a brand ambassador. UNest has received $12.8 million in funding to date. The company continues to experience tremendous growth as it delivers on its mission to democratize financial advice and make college savings accessible for all families. Despite the pandemic, since February, UNest has grown to more than 25,000 users on the app.

InvestmentNews' 40 Under 40 project strives to award the young talent that is rarely recognized in the financial advice industry. By rewarding these honorees, InvestmentNews hopes to reveal the promising future for the industry.

Ksenia, along with the others making the 7th annual 40 under 40 list, is highlighted in the June 29, 2020 issue of InvestmentNews and online at investmentnews.com.

To learn more about Ksenia, the other 2020 winners, awards and the luncheon please visit

www.40under40inadvice.com.

About InvestmentNews

InvestmentNews is the leading source for news, analysis and information essential to the financial advisory community. Since 1998, our standard of editorial excellence and deep industry knowledge has allowed us to educate, inform and engage the most influential financial advisers. Through a weekly newspaper, website, newsletters, research, events, videos and webcasts, InvestmentNews provides exclusive and up-to-the-minute news, as well as actionable intelligence, that empowers financial advisers to serve their clients and run their businesses more effectively whenever, however and wherever they need it.

The InvestmentNews headquarters is located in New York, with offices in Chicago and Washington D.C.

InvestmentNews is part of Bonhill Group Plc.

About UNest

UNest's mobile fintech app helps parents save and grow the money needed to fund their children's education. The UNest team has decades of experience as certified financial advisors, technologists and entrepreneurs. The company partners with financial industry leaders to offer parents a pain-free way to build the best possible educational future for their children. While student debt in the US has reached a historic level of $1.6 trillion, 70 percent of people in the US don't know about 529 plans, and only 14 percent are currently using them due to the complexities associated with the account setup and management. UNest demystifies this process with a paperless approach that takes only five minutes to set up. UNest is a fully accredited and registered financial advisor with SEC and FINRA.

Learn more at www.unestapp.com.

UNest's Android app is available for download here; iOS app is available here.

CONTACT:

Contact: Stephen Sumner
Caliber Corporate Advisers
Email-Address: stephen@calibercorporateadvisers.com
Phone: 917.985.6630 ext.15

SOURCE: UNest

ReleaseID: 595407

BREAKING NEWS!!! (AWARD WINNING Feature Film) “ETHEL”, being distributed by AMGHBO

BREAKING NEWS! BREAKING NEWS! BREAKING NEWS!

ALEXANDRIA, VA / ACCESSWIRE / June 29, 2020 / AMGHBO and Brand Africa has inked a deal and have announced today that the two entities will join in a partnering relationship to deliver nostalgia entertainment worldwide. Brand Africa producing International original content will work in tandem with AMGHBO on its' OTT STREAMING PLATFORM to deliver Original Content, Documentaries & Musical Concerts. The two will continue to operate and perform under its' own guidelines and protocol, with Brand Africa delivering the Ethiopian original content and AMGHBO providing the distribution through its' AMGHBO platform, as well as its' licensing partners platform to include ROKU, APPLE TV, AMAZON FIRE TV, VIMEO, FACEBOOK, YOUTUBE, IG & iOS.

"An AWARD WINNING, Entertaining Film… Full Of Suspense, Romance, And Explosive Action"!!! The feature film entitled, "ETHEL', will keep you glued to your seat, while enjoying the storyline and flawless performance from a cast that delivers an over the top finale.

The visionary (ZELALEM NEGEDE) – Writer, Director and also Star of the film, along with the other phenomenal cast members, Yayirad Mamo, Mulualm Getachew, Fikerte Desalegn and Eyerusalem Gezahhegn are immensely enthusiastic about delivering the excitement from the page of the script to film distribution, to an audience worldwide…

The film starts from an old woman in Ethiopia in a rural part of the country in a village. She has been waiting for a prophecy that has been told to her family and the villagers of her community for a very long time.The prophecy is that there is someone from the 14th generation of her family that will become an Ethiopian King. Unfortunately, the one who could be that person was born in America and not accustomed to the culture of his Ethiopian ancestors. In fact, the life he lived in America was quite the contrary… While living in America, he develops a vast amount of bad habits and one of them was to become a drug dealer. Being in this business, he finds himself in some very compromising situations, in which leads him to be hunted to be killed by some seriously unsavory individuals. Fearing for their son's life, his parents decided to send him to their birthplace Ethiopia for a while, so that he would be safe until things got better at home in America. The enchanting saga begins, while the films' roller coaster ride expands on moving your emotions to a cultivating experience and departs you at the end with an overjoyed fulfillment to conclude.

"ETHEL", A Film by Zelalem Negede will be released July 10th on major Streaming Platforms (Worldwide).

Distributed by: AMGHBO

Distribution Partners:

Facebook, Youtube, Vimeo, IG, Roku, Apple TV, HBO Now, Amazon Fire TV, AMGHBO, and iOS.

OTT Streaming:

Original Content, Documentaries & Musical Concerts.

PPV/TVOD/SVOD

For more information, call AMGHBO @ 703.722.8757

YouTube

Twitter

Vimeo

LinkedIn

Facebook

Instagram

Press/PR Contact:

Ronald R. Chandler
703.722.8757
amghbo1@gmail.com

SOURCE: AMGHBO, Inc.

ReleaseID: 595385

Greenpro Discloses Additional Listed Assets

HONG KONG / ACCESSWIRE / June 29, 2020 / Greenpro Capital Corp. (NASDAQ:GRNQ) (the "Company") today disclosed that it owns shares with a current market value of approximately $185 million of listed OTC companies that are not reflected on the Company's balance sheet.

This stable of assets are listed companies within the Company's incubation model, many of which plan to up-list to a main stock exchange on the HKEX, NASDAQ or NYSE. The Company may at its discretion decide to dividend a portion of such shares to our shareholders or sell some of the shares for cash.

CK Lee, CEO of GRNQ said: "Our Company is committed to maximizing shareholder value through various options, including through the payment of dividends and buyback programs."

The Company announced a spinoff of one million shares of its subsidiary, Millennium Fine Art, Inc., to its shareholders of record on July 1, 2020. "This valuable dividend is an example of our commitment to rewarding our loyal shareholders. We are planning several more dividends this year, said CEO, CK Lee."

About Greenpro Capital Corp.

Headquartered in Hong Kong with strategic offices across Asia, Greenpro Capital Corp. (Nasdaq: GRNQ) is a business incubator and multinational conglomerate with a diversified business portfolio comprising finance, technology, banking, CryptoSx for STOs, health and wellness and fine art. With 30 years of experience in various industries, Greenpro has been assisting and supporting businesses and High-Net-Worth-Individuals to capitalize and securitize their value on a global scale through the provision of cross-border business solutions, spinoffs on major stock exchanges and accounting outsourcing services to small and medium-size businesses located in Asia. The comprehensive range of cross-border business services include, but are not limited to, trust and wealth management, listing advisory services, transaction services, cross-border business solutions, record management services, accounting outsourcing services and tax advisory services. We also operate venture capital businesses, including business development for start-ups and high growth companies, covering finance, technology, FinTech, and health and wellness. For further information regarding the Company, please visit http://www.greenprocapital.com.

About the Millennium Fine Art business

GRNQ is spinning off one million shares of Millennium Fine Art, Inc. ("MFAI"), as a dividend to GRNQ's shareholders of record on July 1, 2020. MFAI is GRNQ's wholly owned subsidiary incorporated in Wyoming and intends to conduct an IPO and list on either the NASDAQ or NYSE. MFAI intends to take the Millennium Sapphire and other art masterpieces on a world tour of museums once they are open to the public, as well as to develop a virtual reality platform including sales and live art auctions.

Forward-Looking Statements This press release contains forward-looking statements, particularly as related to, among other things, the business plans of the Company, statements relating to goals, plans and projections regarding the Company's financial position and business strategy. The words or phrases "plans," "would be," "will allow," "intends to," "may result," "are expected to," "will continue," "anticipates," "expects," "estimate," "project," "indicate," "could," "potentially," "should," "believe," "think," "considers" or similar expressions are intended to identify "forward-looking statements." These forward-looking statements fall within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and are subject to the safe harbor created by these sections. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be cancelled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of local, regional, and global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our periodic reports and on documents we file from time to time with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

GRNQ has 59.16 million shares outstanding and 4.88 million shares in the float.

Gilbert Loke, CFO, director
Greenpro Capital Corp. Email: ir.hk@greenprocapital.com
Phone: +852-3111 7718

Contact Dennis Burns, Investor Relations.
Tel (567) 237-4132
dburns@nvestrain.com

For more information on the Millennium Sapphire please visit: www.millenniumsapphire.com

Facebook: millennium sapphire

SOURCE: Greenpro Capital Corp.

ReleaseID: 595580

Powerbridge Technologies Files Form 20-F for 2019 Annual Results

Highlights a Successful Year with U.S. IPO Listing and 30% Increase in Contracts

ZHUHAI, CHINA / ACCESSWIRE / June 29, 2020 / Powerbridge Technologies Co., Ltd. ("Powerbridge" or the "Company") (NASDAQ:PBTS), a global trade software applications and technology services provider, today announced its financial and operating results for the year ended December 31, 2019. The Company's 20-F filing for its year ended December 31, 2019 was filed with the U.S. Securities and Exchange Commission on June 24, 2020.

Key Financial Highlights for 2019

Revenues $20.1 million.
Gross profit of $6.1 million.
The Company successfully consummated its IPO of 1,750,000 Ordinary Shares at a price of $5.00 per share, raising total gross proceeds of approximately $8.75 million.
Cash balance of $5.7 million at December 31, 2019.

Key Business Highlights for 2019

Increase of 18.8.% in contract amount.
Awarded Contracts of various Powerbridge Smart Solutions for multiple regional regulated zones for international trade.
Launched Big Data Risk Monitoring Platform and Blockchain Cross Border Compliance Platform at Nanning Customs.
Launched Smart Big Data Platforms in new geographical markets, such as Chongqing. Guangdong and Guizhou.
Participated at the Asian Logistics and Maritime Conference.
Demonstrated Powerbridge Smart Port Platform with Strategic Partner Huawei at The Smart China Expo.
Expanded into new markets in Hefei, Chengdu, Ningbo and Chongqing.

Management Commentary

Ban Lor, Co-Chairman and Co-Chief Executive Officer of Powerbridge, commented, "2019 was a successful year in regards to our technology innovation and successful U.S. IPO listing. We invested heavily in both our technology development and capital markets efforts, which we believe set us up for success in the years to come. We incurred an extra $2.5 million expense this past year for our U.S. public listing and expansion into international markets. Our technology team developed and launched new products and services to address the pain points and inefficiencies in global trade compliance, logistics and operations. We are confident that we will return to growth mode once the Covid-19 global pandemic subsides. Additionally, we have embarked on an accretive acquisition strategy and have identified several potential targets. We also look forward to increasing our awareness and communications with shareholders by returning to the U.S. to meet with investors for a non-deal roadshow."

Stewart Lor, President and Chief Financial Officer of Powerbridge Technologies, commented, "In regards to our business operations, it is important to note that no contracts have been cancelled due to the Covid-19 pandemic. However, our business was and has continued being adversely impacted by the outbreak of Covid-19 and our movements remain partially restricted to prevent the second outbreak of Covid-19. Some of our partners and customers had deferred existing and new business, with contracts being pushed out several months. As a result, we have reduced our employee headcount by about 20% as well as identified and implemented additional operating efficiency measures, with our eyes on a return to profitability. Despite of Covid-19, we will continue to grow and optimize our products and services to better serve the emerging needs of the industry. "

We currently derive our revenues from three sources: (1) revenue from application development services generated from Powerbridge System Solutions, which require us to perform services including project planning, project design, application development and system integration based on customers' specific needs. These services also require significant production and customization; (2) revenue from consulting and technical support services primarily generated from Powerbridge System Solutions, and (3) revenue from subscription services generated from Powerbridge SaaS Services.

Our corporate and government customers include (i) international trade businesses and manufacturers, (ii) government agencies and authorities, and (iii) logistics and other various service providers. During the year ended December 31, 2019, we generated revenue from a total of 488 customers, of which 312 are international trade businesses and manufacturers, 29 are government agencies and authorities, and 147 are logistics and other service providers.

2019 Revenue

For the year ended December 31, 2019, our total revenue was approximately $20.1 million as compared to $23.2 million for the year ended December 31, 2018. The Company's total revenue decreased by approximately $3.1 million, or 13.2%. The overall decrease in total revenue was primarily attributable to $4.3 million decrease in revenue from application development services, in which, 6.8% of revenue from application development services service is attributable to the Company's SaaS and big data analysis related application development services in fiscal 2019, which was decreased from 15.6% in fiscal 2018.

The Company's application development service contracts are primarily on a fixed-price basis, which require the Company to perform services including project planning, project design, application development and system integration based on customers' specific needs. These services also require significant production and customization. Revenue from application development service is recognized as work is performed based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligations.

The Company is focusing on developing global trade applications and solutions equipped with the Company's new technology in SaaS platform, Big Data, AI and IoT applications and BaaS platform. The Company believes new technology development is the key driver for the Company's future growth. In 2019, our revenue related to deploying our new technology including SaaS and big data analysis services accounted for 14.8% of our total revenue (or approximately $3.0 million) compared to 17.4% of our total revenue (or approximately $4.0 million) in fiscal 2018.

For the year ended December 31, 2019, our application development service revenue was approximately $15.7 million as compared to $20.0 million for the year ended December 31, 2018. The decrease in application development service revenue was approximately $4.3 million or 21.5% due to less projects completed in fiscal 2019 and reduced individual project size. In certain application development service arrangements, the Company sold IT equipment prior to the delivery of the services. Such revenue was $1,554,428 in fiscal 2019, significantly decreased from $8,069,594 of related revenue in fiscal 2018. In addition, in fiscal 2019, 6.8% (or approximately $1.1 million) of revenue from application development service were related to SaaS platform development and big data analysis applications, comparing to 15.6% (or approximately $3.1 million) of the related revenue in fiscal 2018. Despite to the temporary slowdown in SaaS platform and big data analysis related application development service revenue in fiscal 2019, we intend to continue investing for long-term growth in the SaaS development and big data analysis market and we plan to continue to expand our ability to sell our applications by investing in product development and customer support to address the business needs of local markets and continuous growth for these services.

Revenue from consulting and technical support services is primarily comprised of fixed-fee contracts, which require the Company to provide professional consulting and technical support services over contract terms beginning on the commencement date of each contract, which is the date its service is made available to customers. Billings to the customers are generally on a monthly or quarterly basis over the contract term, which is typically 12 to 24 months. The consulting and technical support services contracts typically include a single performance obligation. The revenue from consulting and technical support services is recognized over the contract term on a straight-line basis as customers receive and consume benefits of such services.

For the year ended December 31, 2019, our consulting and technical support service revenue was approximately $3.3 million as compared to $2.4 million for the year ended December 31, 2018, representing an increase of $0.9 million or 38.3%, which was due to more technical consulting services requests from our existing clients. In addition, by providing application development services, we gain extensive understanding and knowledge of each customer's unique business needs, often resulting in opportunities for us to cross-sell our consulting and technical support services.

Revenue from subscription services is comprised of subscription fees from customers accessing the Company's software-as-a-service applications. The Company's monthly or quarterly billing to customer is on the basis of number of uses or the actual usage by the customers. The subscription services contracts typically include a single performance obligation. The revenue from subscription services is recognized over the contract term on a straight-line basis or based on the actual usage as customers receive and consume benefits of such services.

For the year ended December 31, 2019, our subscription service revenue was approximately $1.1 million as compared to $0.7 million for the year ended December 31, 2018. We introduced our SaaS subscription services in fiscal 2016 and continue to expand the scope of our services and enhance the features and functionalities of our applications and improve our marketing efforts, we expect our subscription service revenue will grow with an expanded offering and increased market awareness.

About Powerbridge Technologies Co., Ltd.

Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) is a provider of software applications and technology solutions and services to corporate and government customers primarily located in China. Founded in 1997, Powerbridge pioneered global trade software applications with a vision to make global trade operations easier for customers. Since inception, Powerbridge has continued to innovate and deliver solutions and services to address the changing needs of thousands of customers. Powerbridge's mission is to make global trade easier by empowering all players in the ecosystem. For more information, visit www.powerbridge.com/en

Forward Looking Statements

No statement made in this press release should be interpreted as an offer to purchase or sell any security. Such an offer can only be made in accordance with the Securities Act of 1933, as amended, and applicable state securities laws. Certain statements in this press release concerning our future growth prospects are forward-looking statements regarding our future business expectations intended to qualify for the "safe harbor" under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding our ability to raise capital on any particular terms, fluctuations in earnings, fluctuations in foreign exchange rates, our ability to manage growth, our ability to realize revenue from expanded operation and acquired assets in China and the U.S., our ability to attract and retain highly skilled professionals, client concentration, industry segment concentration, reduced demand for technology in our key focus areas, our ability to successfully complete and integrate potential acquisitions, and unauthorized use of our intellectual property and general economic conditions affecting our industry. Additional risks that could affect our future operating results are more fully described in our Form 20-F and other filings that we may make with the United States Securities and Exchange Commission in the future. These filings are available at www.sec.gov. Powerbridge may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company's filings with the Securities and Exchange Commission and our reports to shareholders. In addition, please note that any forward-looking statements contained herein are based on assumptions that we believe to be reasonable as of the date of this press release. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.

For more information, please contact:

Corporate:

Powerbridge Technologies Co., Ltd.
Stewart Lor
President and Chief Financial Officer
Email: stewartlor@powerbridge.com

Investor Relations:

ClearThink
Phone: 917-658-7878
Email: nyc@clearthink.capital
Email: IR@powerbridge.com

SOURCE: Powerbridge Technologies Co., Ltd.

ReleaseID: 595586

CARco, a Leader in Automotive Warranty & Protection Products, to Introduce PowerBand’s Virtual Transaction Platform to Nationwide Network of Auto Dealers

VANCOUVER, BC / ACCESSWIRE / June 29, 2020 / PowerBand Solutions Inc. (TSXV:PBX)(OTCQB:PWWBF)(Frankfurt:1ZVA) ("PowerBand", "PBX" or the "Company") is pleased to announce that Comprehensive Auto Resources Company, Inc. ("CARco"), one of the United States' leading administrators of automobile protection products, will be promoting PowerBand's virtual transaction platform to auto dealers across the United States.

CARco is joining with Texas-based D&P Holdings, Inc. ("D&P"), which has partnered with PowerBand, to offer consumers a wide range of vehicle protection products and warranties on the PowerBand virtual transaction platform. When consumers buy, lease, sell and trade vehicles on PowerBand from their smart phone and other digital devices, from any location, they will have access to CARco and D&P vehicle protection products.

CARco is a managing general insurance agency that works with six national insurance companies and more than 1,000 agents, with reach into thousands of auto dealerships nationwide. CARco administers more than 100,000 new vehicle protection products every month in the United States.

"We believe PowerBand is offering a ground-breaking way for consumers and dealers to buy, sell, lease and trade vehicles," said CARco President and CEO Charlie Caronia. "Obtaining vehicle protection products through PowerBand's cloud-based platform is also an important innovation, particularly during this pandemic, and I believe both dealers and insurance agents will see this as a powerful, consumer-friendly tool."

Based in Exton, Pennsylvania, CARco was founded in 2004 to offer automotive dealers and consumers a wide array of vehicle protection and warranty products. Those include Total Loss Protection (TLP), theft protection, tire & wheel and road hazard protection (T&W), GAP and many other products.

"Charlie Caronia and CARco are respected leaders in the automotive warranty business and we are delighted they are joining D&P on the PowerBand platform," said PowerBand CEO Kelly Jennings. "Together, we will be able to offer consumers and dealers a wide array of automotive vehicle protection and insurance products, simply by using a smart phone or tablet."

D&P is one of the United States' largest administrators of automotive warranty and insurance products, directly working with more than 850 dealerships in all 50 states. It is the managing general agency for The Hanover Insurance Group, which has a $3.8-billlion market valuation.

PowerBand's first lease originations are set to begin shortly on its leasing platform operated by MUSA Holdings, LLC ("MUSA"), which PowerBand acquired a 60 per cent share of in July 2019. Founded in 2016, MUSA's innovative transaction platform provides dealers and consumers with the most advanced leasing options in the industry. MUSA takes applications, calculates leases, auto-decisions applications, provides approvals back to dealer partners and prefills lease contracts accurately. Approvals can occur in seconds. As a result of its proprietary technology, MUSA was awarded a contract by Tesla Motors to become a national leasing partner in 2018.

About CARco

Beginning in 2004, armed with a modest staff and agent base, Comprehensive Auto Resources Company, Inc. opened its doors. GAP was still a relatively new product at the time, allowing CARco to use it as the company's main stay, having little competition in the field. As competitors grew, CARco strengthened the breadth of its menu by introducing additional automotive ancillary products. Total Loss Protection (TLP), Theft Protection (Etch), and Tire & Wheel Road Hazard Protection (T&W) were all added, marketed, and implemented in an effort to increase market penetration and to equip Agents with a full arsenal of products. Today, CARco partners with over 1,000 Agents, who provide various automotive products and services to dealerships nationwide.

About PowerBand Solutions Inc.

PowerBand Solutions Inc., listed on the TSX Venture Exchange and the OTCQB markets, is a fintech provider disrupting the automotive industry. PowerBand's integrated, cloud-based transaction platform facilitates transactions amongst consumers, dealers, funders and manufacturers (OEMs). It enables them to buy, sell, trade, finance, and lease new and used, electric- and non-electric vehicles, on smart phones or any other online digital devices, from any location. PowerBand's transaction platform – being trademarked under DRIVRZ – is being made available across North American and global markets.

For further information, please contact:
Richard Goldman, VP Corporate Development
P: 1-866-768-7653
rgoldman@powerbandsolutions.com

FORWARD-LOOKING STATEMENTS

This news release contains forward-looking statements relating to the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding future plans and objectives of the Company, are forward looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. As a result, we cannot guarantee that any forward-looking statement will materialize, and the reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as at the date of this news release, and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by Canadian securities law.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available.

SOURCE: PowerBand Solutions Inc.

ReleaseID: 595566

Aptevo Therapeutics Collects $750,000 Working Capital Escrow From Medexus Related to IXINITY(R) Sale

SEATTLE, WA / ACCESSWIRE / June 29, 2020 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, announced today that it has collected in full the $750,000 placed into an escrow account for working capital adjustments. This collection relates to the Company's sale of its Hemophilia B therapy, IXINITY®, to Medexus Pharmaceuticals.

The sale transaction, completed in February 2020, included an upfront payment to Aptevo of $30 million. In addition, Aptevo is eligible to receive potential milestone payments totaling up to $11 million from Medexus related to the certain regulatory and commercial activities. Also, for up to fifteen years, Aptevo will receive deferred payments on future U.S. and Canadian net sales of IXINITY calculated at a low to mid-single digit percentage of net sales.

About Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The Company's lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603 were developed based on the Company's versatile and robust ADAPTIR™ modular protein technology platform. The ADAPTIR platform is capable of generating highly differentiated bispecific antibodies with unique mechanisms of action for the treatment of different types of cancer. For more information, please visit www.aptevotherapeutics.com

Safe Harbor Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including, without limitation, statements regarding potential milestone payments, Aptevo's outlook, financial performance or financial condition, estimated cash burn, Aptevo's technology and related pipeline, collaboration and partnership opportunities, milestones, and any other statements containing the words "believes," "expects," "anticipates," "intends," "plans," "forecasts," "estimates," "will" and similar expressions are forward-looking statements. These forward-looking statements are based on Aptevo's current intentions, beliefs and expectations regarding future events. Aptevo cannot guarantee that any forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from Aptevo's expectations. Investors are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, Aptevo does not undertake to update any forward-looking statement to reflect new information, events or circumstances.

There are a number of important factors that could cause Aptevo's actual results to differ materially from those indicated by such forward-looking statements, including a deterioration in Aptevo's business or prospects; adverse developments in research and development; adverse developments in the U.S. or global capital markets, credit markets or economies generally; and changes in regulatory, social and political conditions. Additional risks and factors that may affect results are set forth in Aptevo's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, as filed on March 25, 2020 and its subsequent reports on Form 10-Q and current reports on Form 8-K. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from Aptevo's expectations in any forward-looking statement.

Aptevo Therapeutics
Stacey Jurchison
Senior Director, Investor Relations and Corporate Communications
+1 206-859-6628
JurchisonS@apvo.com

SOURCE: Aptevo Therapeutics

ReleaseID: 595508

SeaChange Joins Russell 3000(R) Index

WALTHAM, MA / ACCESSWIRE / June 29, 2020 / SeaChange International Inc. (NASDAQ:SEAC), a leading provider of video delivery platforms, was added to the broad-market Russell 3000® Index at the conclusion of the annual reconstitution of the Russell indexes, effective after the U.S. market opens today, June 29, according to the FTSE Russell website.

Annual Russell indexes reconstitution captures the 4,000 largest U.S. stocks as of May 8, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

"Joining the Russell 3000 Index reflects another important milestone for SeaChange," said CEO Yossi Aloni. "This follows several other achievements for SeaChange, including our transformation into a pure software and cloud solutions provider to the video industry. We expect our inclusion in the Russell 3000 Index will help to increase awareness of our accomplishments and improve liquidity, which should benefit both new and existing investors going forward."

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell's U.S. indexes. Russell indexes are part of FTSE Russell, a leading global index provider.

For more information on the Russell 3000® Index and the Russell indexes reconstitution, go to the "Russell Reconstitution" section on the FTSE Russell website.

About SeaChange International, Inc.

SeaChange International (NASDAQ:SEAC) powers hundreds of cloud and on-premises platforms with live TV and video on demand (VOD) for more than 50 million subscribers worldwide. SeaChange's end-to-end solution, the Framework, enables operators and content owners to cost-effectively launch a direct-to-consumer video service. This includes back-office, media asset management, ad management, analytics and a client application for set-top boxes (STB), Smart-TVs and mobile devices. Framework is available as a product or managed service, and can be deployed on-premises, in the cloud or as a hybrid. For more information, please visit www.seachange.com.

SeaChange Contact:

Matt Glover
Gateway Investor Relations
949-574-3860
SEAC@gatewayir.com

SOURCE: SeaChange Corporation

ReleaseID: 595417

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, SRNE and WFC

NEW YORK, NY / ACCESSWIRE / June 29, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

CytomX Therapeutics, Inc. (NASDAQ:CTMX)

Investors Affected : May 17, 2018 – May 13, 2020

A class action has commenced on behalf of certain shareholders in CytomX Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/cytomx-therapeutics-inc-loss-submission-form/?id=7623&from=1

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)

Investors Affected : May 15, 2020 – May 22, 2020

A class action has commenced on behalf of certain shareholders in Sorrento Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/sorrento-therapeutics-inc-loss-submission-form/?id=7623&from=1

Wells Fargo & Company (NYSE:WFC)

Investors Affected : April 5, 2020 – May 5, 2020

A class action has commenced on behalf of certain shareholders in Wells Fargo & Company. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Wells Fargo planned to, and did, improperly allocate government-backed loans under the Paycheck Protection Program ("PPP"), and/or had inadequate controls in place to prevent such misallocation; (ii) the foregoing foreseeably increased the Company's litigation risk with respect to PPP allocation, as well as increased regulatory scrutiny and/or potential enforcement actions; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/wells-fargo-company-loss-submission-form/?id=7623&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 595587